Prospective trial, single arm, multicentric study. Efficacy and safety of the BTK treatment with luminor DCB.
Prospective, non-randomized multi-center trial with luminor and angiolite BTK.
Physician initiated, prospective, non-randomized multicenter trial, investigating the safety and efficacy of the treatment with the luminor DCB and the iVolution stent of iVascular in TASC C and D femoropopliteal atherosclerotic disease. Preliminary 6-month.
Safety and feasibility study with iVascular angiolite BTK DES as bail out in BTK procedures. 6-month follow-up
Multicenter, randomized and controlled trial to assess the Effectiveness of luminor Paclitaxel-coated balloon catheter versus uncoated balloon catheter in the superficial femoral and popliteal arteries to prevent vessel restenosis or reocclusion. 24-month follow-up.
Physician-initiated trial investigating the Efficacy of the self-expandable ivolution nitinol stent for treatment of femoropopliteal lesions. 24-month follow-up.
Multicentric and prospective study. Real world registry including BTK and SFA lesions. 12-month follow-up of the BTK subgroup available.
Angiographic and optical coherence tomography assessment of the new drug-eluting balloon. 24-month follow-up.
International, multicenter, prospective and observational registry, evaluating the safety and efficacy of angiolite drug eluting stent in non-selected patients from the clinical daily practice.
Non -inferiority randomized and multicenter clinical trial to compare the efficacy and safety of angiolite versus a second-generation drug-eluting stent such as EES.
Multicenter, prospective and observational Trial assessing percutaneous coronary intervention with ANgiolite and Optical CoHerence TOmogrRaphy. 6 months outcomes published at Catheter Cardiovasc Interv. 2017;1-9.
International, multicenter, retrospective and observational registry, studying percutaneous coronary intervention for treating de-novo lesions in small coronary vessels with essential. Published in “Coronary Artery Disease”, Sept 2018.